ncRNA name
hsa-miR-503
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Hepatocellular Carcinoma
Cancer site
Liver
Treatment type
Chemotherapy
Drug
Adriamycin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
HepG2/ADM cells overexpressing miR-503 demonstrated an enhanced sensitivity to ADM.
Tissue resource
human hepatocellular carcinoma cell lines HepG2
Experiment
qRT-PCR,Western blot
Institute
the Cell Bank of the Chinese Academy of Sciences
Country
China
Continent
Asia